Shawn Seamans, Chief Commercial Officer, CoverMyMeds | Authors | Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for taking ...

RxLogic's Ann Beal on how PBM reform indirectly impacts pharma manufacturers' affordability programs, rebate planning, and patient access.

Wilhelm's comments describe a supply chain strategy built around flexibility, balancing inventory positioned close to ...

Geopolitical supply chain mapping identifies hidden dependencies across corridors, ports, airports, customs gateways, and carriers that can undermine continuity despite apparent supplier ...

How commercial trade groups are shifting from distribution execution to strategic partners shaping market access, launch readiness and commercial performance. This evolution reflects a broader shift ...

In this week's Pharma Pulse, Cardinal Health expands its at-Home Solutions business with two acquisitions, President Trump lays out a phased tariff schedule for generic drugs, and Novo Nordisk sues ...

Medicaid work requirements under the One Big Beautiful Bill Act demand employment/volunteering documentation and clinician attestations, while exemption severity criteria vary by state and may be ...

Amy Niles of the Patient Advocate Foundation revisits her 2026 outlook on prior authorization reform and the Medicare Prescription Payment Plan. Pharmaceutical Commerce continues its H1 Review/H2 ...

Rising U.S. prescription spending heightens urgency to identify when to trigger clinical review, discontinue payment, or shift to lower-cost options before avoidable spend accrues. “Subtraction ...

Claims target comparative ads that juxtapose tirzepatide’s maximum tolerated doses with semaglutide regimens that omit FDA-approved higher strengths, potentially creating a misleading efficacy ...